A detailed history of Bluefin Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 56,500 shares of MRK stock, worth $5.41 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
56,500
Holding current value
$5.41 Million
% of portfolio
0.49%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $401,857 - $438,006
3,700 New
3,700 $426,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $1.64 Million - $2.11 Million
18,800 Added 179.05%
29,300 $3.25 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $693,146 - $778,672
8,200 Added 356.52%
10,500 $904,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $217,074 - $246,064
-2,600 Reduced 53.06%
2,300 $213,000
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $1.1 Million - $1.23 Million
-14,928 Reduced 75.29%
4,900 $402,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $328,223 - $411,142
4,541 Added 29.7%
19,828 $1.52 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $2.86 Million - $3.14 Million
-39,834 Reduced 72.27%
15,287 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $3.16 Million - $3.49 Million
44,916 Added 440.14%
55,121 $4.29 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $179,036 - $210,886
2,600 Added 34.19%
10,205 $787,000
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $105,860 - $117,483
1,475 Added 24.06%
7,605 $622,000
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $448,593 - $508,483
6,130 New
6,130 $508,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.